AB

Ada B.

Director Of Supply Chain And Demand Planning at C2 PHARMA

Ada B. has extensive experience in supply chain and customer service roles, primarily at C2 Pharma since September 2016, where Ada serves as Director of Supply Chain and Demand Planning, having progressed through various managerial positions. Prior to C2 Pharma, Ada worked at TSRC Corporation from August 2013 to August 2016 as a Customer Service Representative, managing orders and logistics for clients across Europe, Asia, and the Middle East. Ada's earlier experience includes roles at GEZE Poland, where Ada specialized in customer service for automated systems, and KSB Pumps and Industrial Sanitary Products, where Ada supported sales operations. Ada holds a Master's Degree in Clinical Psychology from Uniwersytet SWPS.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


C2 PHARMA

C2 PHARMA (http://www.c2pharma.com) is a pharmaceutical group established in 2014. It manufactures and distributes active pharmaceutical ingredients (APls) and complex chemical compounds obtained from natural and synthetic origins. The current API product portfolio includes cyclopentolate, atropine, digoxin, homatropine, pilocarpine, brimonidine, latanoprost, bimatoprost and reaches more than 100 pharmaceutical companies across the United States, Western and Eastern Europe, South America, Asia, Middle-East and Africa. C² PHARMA also offers customized cold-chain logistics solutions through its specialized affiliate Logistics4Pharma  (http://www.logistics4pharma.com) as well as R&D-scale synthesis services of complex organic molecules and impurities through its affiliate ASM Research Chemicals (http://www.asm-research-chemicals.de). C² PHARMA is a key sponsor of the “Partnership for a Better World” program that ensures a sustainable, traceable & fair-trade harvesting and sourcing of phytochemical and botanicals used for pharmaceutical APIs such as Pilocarpine. The program sustains of more than 1,000 families and contributes to the preservation of the Brazilian biodiversity. #c2Pharma; #C²Pharma; #c2 Pharma; #C² Pharma; #Centroflora CMS